Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
Would you consider anti-CD20 agents for treatment of multiple sclerosis in patients with history of breast cancer?
Related Questions
Can you use leflunomide and rituximab in a patient with both multiple sclerosis and rheumatoid arthritis?
How do you workup patients with neuropathy suspected to be secondary to sarcoid?
What is your approach to DVT prophylaxis in patients who require IVIG but are at increased risk for thrombotic events?
Do you send CSF or serum ACE levels in the workup of neurosarcoidosis?
How do you treat solitary sclerosis?
If a patient develops itching with their first dose of Tysabri despite pre-treatment, does this indicate that further cycles of Tysabri are contraindicated or do you continue Tysabri at the next cycle?
Do you see a current or future clinical role of neurofilament light chain in the diagnosis or workup of multiple sclerosis?
How do you dose steroids in neurosarcoidosis patients with a worsening clinical symptoms or MRI findings?
What is your approach to dosing rituximab in patients with multiple sclerosis?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
